Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus
Frontiers in Pediatrics · 15.02.2023 · 11
DOI: 10.3389/fped.2023.1109646 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 15.02.2023. Verfasst von Daniel Hurtado-Sierra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology Unit, Instituto del Corazón de Bucaramanga, Bucaramanga, Colombia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiac rhabdomyoma (CRHM) is the principal cardiac tumor in children and is most often associated with tuberous sclerosis complex (TSC). Mutations in the TSC1 and TSC2 genes cause the overactivation of the mammalian Target of Rapamycin (mTOR). This protein family is responsible for abnormal cell proliferation leading to the formation of CRHMs and hamartomas in other organs. Despite the tendency for spontaneous regression, some CRHMs can cause heart failure and intractable arrhythmias, requiring surgical resection. In recent years, the use of everolimus and sirolimus (mTOR inhibitors) in the treatment of CRHMs has been reported. We report two cases of neonates with giant rhabdomyomas, with hemodynamic repercussions treated with low-dose everolimus (4.5 mg/m 2 /week). In both cases, we obtained an approximate decrease of 50% in the total area of the mass after three weeks of treatment. Despite rebound growth after stopping the drug, we were able to evidence that the use of low doses of everolimus immediately after birth is effective and safe in the treatment of giant CRHMs, avoiding surgical resection of the tumor and associated morbidity and mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Cardiology Unit, Instituto del Corazón de Bucaramanga, Bucaramanga, Colombia.
- Nursing School, Universidad Industrial de Santander, Bucaramanga, Colombia.
- Research Center, Fundación Cardiovascular de Colombia, Floridablanca, Colombia.
Zitieren
APA
Hurtado-Sierra, D., Ramos Garzón, J. X., Rojas, L. Z., Fernández-Gómez, O., & Manrique-Rincón, F. (2023). Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1109646
Vancouver
Hurtado-Sierra D, Ramos Garzón JX, Rojas LZ, Fernández-Gómez O, Manrique-Rincón F. Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1109646
BibTeX
@article{HurtadoSierra2023,
author = {Hurtado-Sierra, Daniel and Ramos Garzón, Judy Ximena and Rojas, Lyda Z and Fernández-Gómez, Oscar and Manrique-Rincón, Francisco},
title = {Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus},
journal = {Frontiers in Pediatrics},
year = {2023},
volume = {11},
doi = {10.3389/fped.2023.1109646}
}
EUVIMED